Literature DB >> 24975097

Effect of cyclooxygenase (COX)-2 inhibition on mouse renal interstitial fibrosis.

Shigeyoshi Honma1, Masahiro Shinohara2, Naho Takahashi2, Kazuki Nakamura2, Shohei Hamano2, Satoru Mitazaki2, Sumiko Abe2, Makoto Yoshida2.   

Abstract

Unilateral ureteral obstruction (UUO) is a well-established model for the study of interstitial fibrosis in the kidney. In this study, we investigated the effects of a COX-2 inhibitor, meloxicam, on UUO-induced renal interstitial fibrosis in mice. Serum creatinine, blood urea nitrogen and urinary glucose were significantly increased by UUO. However, all of these changes were attenuated by meloxicam (1 mg/kg/day). Masson׳s trichrome staining showed that interstitial fibrosis was significantly increased by UUO, but that meloxicam also significantly diminished the area of UUO-induced fibrosis. Heat shock protein (HSP) 47 protein, a collagen-specific molecular chaperone essential for the biosynthesis of collagen molecules, and type IV collagen mRNA were increased in kidneys of UUO mice. Meloxicam reduced the expression of both HSP47 protein and type IV collagen mRNA. The phosphorylation of extracellular regulated kinase (ERK) and c-jun-N-terminal kinase (JNK) was increased by UUO, but these changes were inhibited by meloxicam. Collectively, these results suggest that COX-2 may be involved in the expression of HSP47 and type IV collagen through the phosphorylation of ERK and JNK, accelerating renal interstitial fibrosis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COX-2 inhibitor; Fibrosis; Heat shock protein (HSP) 47; Meloxicam (PubChem CID: 54677470); Type IV collagen; Unilateral ureteral obstruction (UUO)

Mesh:

Substances:

Year:  2014        PMID: 24975097     DOI: 10.1016/j.ejphar.2014.06.027

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Role of COX-2 in unilateral ureteral obstruction: what is new?

Authors:  Tianxin Yang; Chunling Li
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-09

Review 2.  Genetic and epigenetic regulation of intestinal fibrosis.

Authors:  Chao Li; John F Kuemmerle
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

3.  Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis.

Authors:  Elisabeth Schinner; Veronika Wetzl; Andrea Schramm; Frieder Kees; Peter Sandner; Johannes-Peter Stasch; Franz Hofmann; Jens Schlossmann
Journal:  FEBS Open Bio       Date:  2017-03-01       Impact factor: 2.693

4.  Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin.

Authors:  Veronika Wetzl; Elisabeth Schinner; Frieder Kees; Franz Hofmann; Lothar Faerber; Jens Schlossmann
Journal:  Front Pharmacol       Date:  2016-07-12       Impact factor: 5.810

Review 5.  Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney.

Authors:  Rikke Nørregaard; Tae-Hwan Kwon; Jørgen Frøkiær
Journal:  Kidney Res Clin Pract       Date:  2015-11-12

6.  Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture.

Authors:  Dong-Ru Ho; Shih-Horng Su; Pey-Jium Chang; Wei-Yu Lin; Yun-Ching Huang; Jian-Hui Lin; Kuo-Tsai Huang; Wai-Nga Chan; Chih-Shou Chen
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.